InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by HARDY REGINALD L, Président. Insider active across 2 companies, notably Brickell Biotech, Inc.. In total, 3 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €113k. Activity tracked since 23 July 2021. The latest transaction was disclosed on 31 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
15,180 shares@ US$0.22895.2% of flowCommon StockSEC:0000819050-22-000005:0
100,000 shares@ US$0.6623100.0% of flowCommon StockSEC:0000819050-21-000125
Ideal exit: 19 Apr 2022 (T+270)
100,000 shares@ US$0.662394.8% of flowCommon StockSEC:0000819050-21-000125:0
Ideal exit: 19 Apr 2022 (T+270)
3 of 3 declarations
About HARDY REGINALD L
Reginald L. Hardy is the Chairman of the Board of Brickell Biotech, Inc. He oversees the activities of the board and plays a key role in defining the company's strategy. His experience in the biopharmaceutical sector is an asset in guiding Brickell Biotech towards its objectives.
